Skip to main content
DNA Labs India

DDHD1 Gene SPG28 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

DDHD1 Gene SPG28 NGS Genetic Test

Short Name: DDHD1 SPG28 NGS Test

Also known as: DDHD1 Gene Test, SPG28 Genetic Test, Hereditary Spastic Paraplegia Type 28 NGS Test

DDHD1 Gene SPG28 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in The report is usually ready in 3 to 4 weeks after the sample is received by the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to detect pathogenic or likely pathogenic variants in the DDHD1 gene that are associated with SPG28. A confirmed molecular diagnosis can help guide clinical management, support genetic counseling, clarify recurrence risks for family members, and assist in reproductive planning.

Test Code
4528
ICD Code
G11.4
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
The report is usually ready in 3 to 4 weeks after the sample is received by the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation such as fasting is required. A genetic counseling session to draw a pedigree chart of family members affected with DDHD1 Gene SPG28 Disease is recommended before testing. Please carry prior medical records, imaging reports, and family history information.

Method: Peripheral blood sampling / FTA card blood spot / Extracted DNA submission

Step 2

Laboratory Analysis

A trained phlebotomist will collect a blood sample, submit an extracted DNA sample, or collect one drop of blood on an FTA card using sterile equipment. The procedure is routine and takes only a few minutes.

Step 3

Report Delivery

After sample collection, you can resume normal activities. If you experience bleeding or bruising at the puncture site, apply gentle pressure. The laboratory will provide an estimated report date and updates as needed.

Timeline: The report is usually ready in 3 to 4 weeks after the sample is received by the laboratory.

Patient Instructions

1
Before the Test:No special preparation such as fasting is required. Genetic counseling to discuss the family pedigree and clinical history is recommended before proceeding with the test.
2
During the Test:The sample is collected using a simple blood draw, FTA card, or provided extracted DNA. The procedure carries minimal risk.
3
After the Test:After sample collection, you may continue normal daily activities. The laboratory will send the report through the chosen delivery method once available.

About This Test

Who Should Get This Test

The purpose of this test is to detect pathogenic or likely pathogenic variants in the DDHD1 gene that are associated with SPG28. A confirmed molecular diagnosis can help guide clinical management, support genetic counseling, clarify recurrence risks for family members, and assist in reproductive planning.

How to Prepare

  • No fasting is required
  • Informed consent and genetic counseling are required before testing
  • FTA cards must be labeled and dried after the blood spot is applied
  • Extracted DNA samples must be clearly labeled with patient identifiers

Doctor's Notes

Reviewed by — MBBS, MD (General Medicine) · Reg. No. 8052

"Hereditary spastic paraplegia is a clinical diagnosis supported by genetic testing. In women planning pregnancy, preconception counseling and carrier testing can provide useful information when a DDHD1 mutation is identified in the family."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs per laboratory requirement
ContainerEDTA tube / FTA card
Collection MethodPeripheral blood sampling / FTA card blood spot / Extracted DNA submission

Sample Stability

EDTA blood should be transported to the laboratory promptly24-48 hours
EDTA blood if transport is delayedUp to 7 days
Extracted DNALong term
FTA card stored dry in a protective pouchSeveral months
Sample Rejection Criteria:
  • Hemolysed or clotted blood sample
  • Inadequate sample quantity
  • Mislabeled or unlabeled sample
  • Sample that does not meet laboratory quality requirements

Understanding Your Results

All detected variants are classified according to the American College of Medical Genetics and Genomics (ACMG) guidelines. Results should be interpreted by a clinical geneticist in the context of the patient's symptoms, family history, and other clinical findings.
📊

Pathogenic or likely pathogenic variant detected

Supports the clinical diagnosis of SPG28 and helps guide clinical care, management, and genetic counseling.

📊

Variant of uncertain significance (VUS)

Requires additional family segregation studies or further molecular testing; cannot be used alone to confirm or exclude SPG28.

📊

No pathogenic variant detected

Reduces the likelihood of SPG28, but does not exclude other hereditary spastic paraplegia genes or other genetic mechanisms.

⚠️ When to Consult a Doctor:

Consult a neurologist or clinical geneticist if you or a family member have unexplained leg weakness, spasticity, gait problems, balance difficulties, or foot deformities. Genetic counseling is also advised before and after testing to understand the implications of the result.

Limitations

  • This test analyzes only the DDHD1 gene and will not detect mutations in other genes responsible for hereditary spastic paraplegia
  • A variant of uncertain significance (VUS) may require additional family studies
  • A negative result does not completely exclude SPG28 because deep intronic variants or other variant types may not be covered by the NGS assay

Risks & Considerations

  • Pain or bruising at the blood collection site
  • Bleeding or hematoma
  • Infection at the puncture site (rare)
  • Anxiety or dizziness during blood collection
  • Psychological impact of receiving a genetic test result

Interfering Factors

  • Clinically similar phenotypes may be caused by mutations in other genes not covered by this test
  • Degraded or contaminated DNA may affect sequencing quality
  • Certain types of variants, such as large structural rearrangements, may not be detected depending on the assay

Frequently Asked Questions

What is the DDHD1 Gene SPG28 NGS Genetic Test?
It is a genetic test that uses next-generation sequencing to detect disease-causing mutations in the DDHD1 gene associated with SPG28, a rare hereditary spastic paraplegia.
What does SPG28 mean?
SPG28 stands for Spastic Paraplegia type 28, a rare inherited neurological condition that affects movement by causing spasticity and weakness in the legs.
What are the symptoms of SPG28?
Symptoms may include weakness in the legs, stiffness or spasticity, difficulty walking or running, foot deformities, and balance problems. Symptoms can vary from person to person.
How is SPG28 inherited?
SPG28 is inherited in an autosomal recessive manner. A person usually needs to inherit two altered copies of the DDHD1 gene, one from each parent, to develop the condition.
What type of sample is required?
The test can be performed on blood, extracted DNA, or one drop of blood placed on an FTA card.
Is fasting required before the test?
No, fasting is not required for the DDHD1 Gene SPG28 NGS Genetic Test.
How long does the test take?
The reports are generally available within 3 to 4 weeks after the sample is received by the laboratory.
Do you provide home sample collection?
Yes, home sample collection is available for online bookings across many cities in India, including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, and others.
What is the cost of the test?
The special discounted price of the test is INR 20,000, which includes genetic counseling and support.
Who should take this test?
Adults and children with symptoms suggestive of hereditary spastic paraplegia, or those with a confirmed family history of SPG28, may be considered for testing. Genetic counseling is strongly recommended first.
What do the test results mean?
A pathogenic or likely pathogenic variant in the DDHD1 gene supports the diagnosis of SPG28. If no variant is found, SPG28 is less likely but not completely ruled out, because the test is limited to the DDHD1 gene and certain variant types.
Is genetic counseling included with this test?
Yes, genetic counseling is part of the test process to discuss the family history, possible implications, and results with a qualified doctor.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.